Sort
40,608 grants matching “prostate cancer”
Role of CPT1A as a lysine succinyltransferase in tumorigenesis
$363,713Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2020 · CA
Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow
$363,707Michael R King · Vanderbilt University · R01 · FY2022 · CA
RASL-Seq Expression Profiling of FFPE Tissues
$363,706Joanne Mulligan Yeakley · Biospyder Technologies, Inc. · R33 · FY2015 · CA
GENETIC STUDIES OF GOOD HEALTH IN AN AGING TWIN COHORT
$363,680Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2001 · AG
FACILITATING DISCOVERY THROUGH A HUMAN PROSTATE TISSUE R
$363,662Medical College Of Wisconsin · U01 · FY2002 · CA
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
$363,660Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · U01 · FY2025 · CA
Molecular and fate maps of prostatic stroma
$363,660Chad M Vezina · University Of Wisconsin-Madison · U01 · FY2018 · DK
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells
$363,583Jenny Zilberberg · Hackensack University Medical Center · R33 · FY2017 · CA
Validation of predictive liquid biomarkers for patients with metastatic prostate cancer
$363,463Joshua Michael Lang · University Of Wisconsin-Madison · UH3 · FY2023 · CA
Phase I/II trial of green tea and quercetin in docetaxel chemotherapy
$363,452Piwen Wang · Charles R. Drew University Of Med & Sci · U54 · FY2025 · MD
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2010 · CA
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2008 · CA
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2009 · CA
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2007 · CA
Quantitative Analysis of Epidermal Growth Factor Receptor Signaling Networks
$363,410Forest M White · Massachusetts Institute Of Technology · R01 · FY2008 · CA
A Novel Lineage Specific Metastasis Suppressor Pathway in Lung Cancer
$363,372Don X Nguyen · Yale University · R01 · FY2013 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$363,351James A Wells · University Of California, San Francisco · R01 · FY2021 · CA
A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments
$363,342Lei Ren · Duke University · R01 · FY2016 · CA
A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments
$363,342Lei Ren · Duke University · R01 · FY2017 · CA
Chlorotoxin as a Targeting Agent for Cancer Therapies
$363,308James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
INVESTIGATING THE MULTIFACETED IMPACT OF HIF-1 DURING PROSTATE CANCER AND ITS POTENTIAL VALUE AS A THERAPEUTIC TARGET
$363,296The Johns Hopkins University · · FY2014 · Department of the Army
miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer
$363,250Murali Mohan Yallapu · University Of Texas Rio Grande Valley · SC1 · FY2023 · GM
miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer
$363,250Murali Mohan Yallapu · University Of Texas Rio Grande Valley · SC1 · FY2024 · GM
miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer
$363,250Murali Mohan Yallapu · University Of Texas Rio Grande Valley · SC1 · FY2021 · GM
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
$363,250Michael H Elliott · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · EY